Healthcare

What will FDA’s experts review at their first COVID-19 vaccine hearing? Agency documents set the tone

The countdown to the FDA’s first coronavirus vaccine hearing has begun. More than seven months ...

By Value Spots

6 hours ago

Healthcare

Survey found insurance premiums grew faster than inflation in 2020

According to Kaiser Family Foundation’s recent survey on employer health benefits, premiums for people with ...

By Value Spots

15 hours ago

Healthcare

Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report

Sanofi is in the middle of an ambitious reorganization, spearheaded by CEO Paul Hudson, to ...

By Value Spots

23 hours ago

Healthcare

Agios’ Tibsovo has an FDA green light in AML. Why did European regulators turn it back?

Agios may have persuaded the FDA into doling out an approval for its acute myeloid ...

By Value Spots

1 day ago

Healthcare

Pfizer plans to ditch Perth sterile injectables manufacturing site by 2024, endangering 470 positions

After years of manufacturing woes, Pfizer appeared to turn a corner earlier this year for its ...

By Value Spots

2 days ago

Healthcare

Hey investors, COVID-19 vaccine manufacturing partner Emergent won’t suffer from AZ, J&J trial holds: analysts

Shares of Emergent BioSolutions have been on a roller coaster of late, plummeting last month ...

By Value Spots

2 days ago

Healthcare

Cytiva tasked with COVID-19 vaccine work as part of $31M U.S. government grant

With the U.S. working at a rapid clip to scale capacity for a range of ...

By Value Spots

2 days ago

Healthcare

Orexo backs up new digital therapeutic launches with social, online marketing

Orexo didn’t plan to go as fast as it has in launching its digital therapeutics in ...

By Value Spots

3 days ago

Healthcare

DNA maker Touchlight adds Lonza manufacturing vet as it swings at COVID-19 vaccine, cell and gene therapy markets

With dozens of approvals expected in the coming years, the cell and gene therapy space ...

By Value Spots

3 days ago

Healthcare

Merck, plagued by limited supply of bladder cancer drug, will build new facility to triple production

During its years as sole producer of a difficult-to-make cancer med in high demand, Merck ...

By Value Spots

3 days ago

Healthcare

What will FDA’s experts review at their first COVID-19 vaccine hearing? Agency documents set the tone

Survey found insurance premiums grew faster than inflation in 2020

Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report

Agios’ Tibsovo has an FDA green light in AML. Why did European regulators turn it back?

Pfizer plans to ditch Perth sterile injectables manufacturing site by 2024, endangering 470 positions

Hey investors, COVID-19 vaccine manufacturing partner Emergent won’t suffer from AZ, J&J trial holds: analysts

Cytiva tasked with COVID-19 vaccine work as part of $31M U.S. government grant

Orexo backs up new digital therapeutic launches with social, online marketing

DNA maker Touchlight adds Lonza manufacturing vet as it swings at COVID-19 vaccine, cell and gene therapy markets

Merck, plagued by limited supply of bladder cancer drug, will build new facility to triple production

Posts List

Should You Buy a Next Gen Xbox or PlayStation Console?

Seeing Beyond The Black Swan Event – Part 2

Value investing: Valuation-driven investing for investment success: 8 key tips

Categories

Healthcare

Posts List

Categories

Latest Posts